Envoy Medical, Inc. COCH
Set alert
6.83 USD +0.18 +2.71%
As of Nov 3, 2:04 PM ET
6.72 Day range 7.00
3.63 52-week range 9.54
- YTD
- +3.33%
- 1 year
- -10.60%
- Open
- 6.72
- Prev close
- 6.65
- Mkt cap
- 53.45M
- Vol
- 5.79K
- Avg vol
- 12.36K
- EPS
- -7.60
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.72
- High
- 7.00
- Forward P/E
- -1.43
- Beta
- 2.36
- Short ratio
- 1.75
- Inst. own
- 6.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 2.25
- 200-d avg
- 3.10
- 1y target
- 6.50
6M chart
Events in this range
- Oct 26, 2026Split: 1 for 10
Signals (54)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 2026 | 5 hours ago |
| MACD: Buy Signal | Oct 27, 2026 | 1 week ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 2 months ago |
| SMA: Bullish | Sep 3, 2026 | 2 months ago |
| SMA: Bullish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
Newest 20 of 54.
Analyst view
Price target (mean) 6.50 -4.8% downside
Now 6.83
- Target (low)
- 5.00
- Target (mean)
- 6.50
- Target (high)
- 9.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.31333 | -0.36 – -0.25 | 0.00 | 0.0% | 77.50K | -18.4% | 3 |
| Next quarter | -0.34333 | -0.42 – -0.28 | -0.32 | -7.3% | 78.33K | +32.8% | 3 |
| Current year | -1.28 | -1.33 – -1.21 | -2.38 | +46.2% | 258.75K | -18.1% | 3 |
| Next year | -1.26 | -1.39 – -1.15 | -1.28 | +1.6% | 325.00K | +25.6% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 6, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Oct 14, 2024 | Brookline Capital | Initiated | — | Buy |
| Sep 3, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Jun 24, 2024 | Ascendiant Capital | Initiated | — | Buy |
| Apr 3, 2024 | Lake Street | Maintained | Buy | Buy |
| Dec 21, 2023 | Northland Capital Markets | Initiated | — | Outperform |
| Nov 28, 2023 | Lake Street | Initiated | — | Buy |